225Ac-ABD147

· Abdera Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 225Ac-ABD147, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy [Phase 1]

See pricing